Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

September 6, 2020
Open Access

Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts

Nature Communications
Sara R RashkinJohn S Witte
September 5, 2020
Open Access

Approximating dementia prevalence in population-based surveys of aging worldwide: An unsupervised machine learning approach

Alzheimer's & Dementia : Translational Research & Clinical Interventions
Laurent Cleret de LangavantKristine Yaffe
September 5, 2020
Open Access

Transition from physical to virtual visit format for a longitudinal brain aging study, in response to the Covid-19 pandemic. Operationalizing adaptive methods and challenges

Alzheimer's & Dementia : Translational Research & Clinical Interventions
Chinedu Theresa Udeh-MomohLefkos T Middleton
September 13, 2020

Content of Home-Based Dementia Care: Adverse Consequences of Unmet Toileting Needs

Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society
Jennifer M ReckreyKatherine A Ornstein
September 8, 2020

Exercise Types and the Risk of Developing Cognitive Decline in Older Women: A Prospective Study

Journal of Alzheimer's Disease : JAD
Yosuke OsukaHunkyung Kim
September 9, 2020
Open Access

Cerebrovascular risk factors impact frontoparietal network integrity and executive function in healthy ageing

Nature Communications
Michele VeldsmanMasud Husain
September 15, 2020

Brainstem Volumetric Integrity in Preclinical and Prodromal Alzheimer's Disease

Journal of Alzheimer's Disease : JAD
Shubir DuttAlzheimer’s Disease Neuroimaging Initiative
September 16, 2020

Age-related changes in the immune system and cognitive disorders in vascular dementia and Alzheimer's disease

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
M B Nuvakhova, S A Rachin
September 10, 2020

Representation of Older Latinxs in Cohort Studies at the Rush Alzheimer's Disease Center

Neuroepidemiology
David X MarquezDavid A Bennett
September 15, 2020

Cognitive, Genetic, Brain Volume, and Diffusion Tensor Imaging Markers as Early Indicators of Dementia

Journal of Alzheimer's Disease : JAD
Theresa MüllerErika J Laukka
September 14, 2020

The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Mohamad HabesiSTAGING consortium, the Preclinical AD consortium, the ADNI, and the CARDIA studies
September 15, 2020

Correlates of Formal Support Service Use among Dementia Caregivers

Journal of Gerontological Social Work
Sara J FeldmanJ Scott Roberts
September 16, 2020

Mechanisms of Cerebral Microbleeds

Journal of Neuropathology and Experimental Neurology
Lara C WadiMark J Fisher
September 5, 2020
Open Access

Predictors of olfactory decline in aging: A longitudinal population-based study

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
Ingrid EkströmErika J Laukka
September 8, 2020
Open Access

A consideration of the effects of aging on psychosomatic symptoms in the elderly

Rinshō shinkeigaku = Clinical neurology
Kazuhiro Niizato

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

© 2020 Meta ULC. All rights reserved
/feed-previews/aging-epidemiology/a9c8dd1c-63f7-411f-9565-a289f8e64eeb